Spruce Street Capital LP: KINIKSA PHARMACEUTICALS I (KNSA): Quarterly 13F Position History
As of Q1 2026, Spruce Street Capital LP reported 761,063 shares of KINIKSA PHARMACEUTICALS I (KNSA), worth $36.6M and representing 8.8% of its 13F equity book. Quarter-over-quarter share count change: + 326,081 (+75.0%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 761,063Shares Held (Latest Filing)
- $36.6MReported Market Value (Latest Filing)
- 8.8%Portfolio Weight (% of 13F Equity Book)
- +326,081Quarter-over-Quarter Share Change
- +$18.7MQuarter-over-Quarter Value Change
- 761,063Peak Reported Shares (Historical)
Recent initiation: Spruce Street Capital LP first reported KNSA on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 761,063 | +326,081 | +75.0% | $36.6M | 8.8% | $48.1 |
| Q4 2025 | 434,982 | — | — | $17.9M | 5.9% | $41.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Spruce Street Capital LP first disclose a KNSA position in 13F-HR filings?
Spruce Street Capital LP first reported KINIKSA PHARMACEUTICALS I (KNSA) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Spruce Street Capital LP's most recent quarter-over-quarter share-count change in KNSA?
Between Q4 2025 and Q1 2026, Spruce Street Capital LP added 326,081 shares of KNSA (+75.0%), bringing the total reported position to 761,063 shares at a market value of $36.6M.
Does the implied price-per-share represent Spruce Street Capital LP's cost basis in KNSA?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.